International trends and patterns of primary liver cancer.
about
Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinomaChinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancerDrug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinomaTransarterial (chemo)embolisation for unresectable hepatocellular carcinomaCombination of three-dimensional conformal radiotherapy and transcatheter arterial chemoembolisation versus transcatheter arterial chemoembolisation for primary hepatocellular carcinomaDiagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-AnalysisTargeted therapy for hepatocellular carcinoma: novel agents on the horizonHepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experienceHcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinomaRNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cellsToxicology of microcystins with reference to cases of human intoxications and epidemiological investigations of exposures to cyanobacteria and cyanotoxins.Cluster of liver cancer and immigration: a geographic analysis of incidence data for Ontario 1998-2002.Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.Intrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell line.Current management of hepatocellular carcinoma.HCV-related mortality among male prison inmates in Texas, 1994-2003.Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.Hepatocellular adenoma in a Eurasian otter (Lutra lutra)Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patientsTime trends of incidence of digestive system cancers in changle of China during 1988-2002.Comparing outcomes of two vascular inflow occlusion techniques and treatment without vascular occlusion during major hepatectomy in patients with Hepatitis B-related hepatocellular carcinomaInsulin-like growth factors and liver cancer risk in male smokers.Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.Epidemiology of primary and secondary liver cancers.Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).Serological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseases.Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR.Increased risk of hepatocellular carcinoma after cholecystectomy.International trends in primary liver cancer incidence from 1973 to 2007.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.Hepatocellular carcinoma in Asia: Prevention strategy and planning.Decreased PCSK9 expression in human hepatocellular carcinoma.Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma.Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
P2860
Q24187663-FCC32020-68F9-4946-AF81-F54BCC715048Q24201014-78A62661-B16F-4500-B008-CCB7E6AF524DQ24202061-A94CEFA0-2F8B-483A-8526-421BA9291183Q24235977-EC04781A-31AA-4F58-BC35-E407EB60A360Q26471711-2595CBA7-D7F7-4B7F-9663-213D22EE298CQ26863560-9651161E-68F3-4690-90EA-803FFAB3F282Q27002288-7A894183-2159-444D-B689-A1D3E30BF358Q27490250-1BB02B02-DA19-479F-911E-7D1A7A9CC5B4Q28304534-E44A4E6E-35B3-4381-BB63-50872783FC2FQ28383116-BB12D001-3EF2-422B-A538-2F7ECDE14B4AQ30239833-FD9FD24A-B53F-4E06-9D78-F9E9F1DCB9CAQ31157318-FCE115EB-CEC4-4931-A70F-87A24EBAE32FQ33248446-74FCF62D-69EE-4F9A-BD50-98DAB71996F2Q33414397-480B888A-414E-4785-9A05-BD3C2BACF232Q33582165-60ABFF6F-B55B-4366-9FED-ED7CE2C021DDQ33802968-685344D2-BA18-459E-9821-F5DF100A4FE5Q33827983-8061F7EB-36C6-450F-A1E4-D22D49043B4BQ33860705-C92F1572-465F-427C-99AD-1AABB9FE0B87Q33866403-B5259322-0CFC-41CA-BE83-FEE30FBD218FQ33866448-47BF0912-95DF-4DED-80DD-C0BB26AD593AQ33977186-01F34D2E-26BF-4008-A2F6-F46E202FD31EQ34017694-AE01E529-E2C3-42CD-B3D4-0A590784D334Q34156103-A8B346E2-8964-4B3A-9739-1E1F9C423BDBQ34250082-C1109D67-90D3-4EFD-917A-6ACEC5F23795Q34408236-16180926-26F5-4D5C-8F95-0DF2CDF0A19EQ34531474-0A965F33-45F0-4EAD-AE10-3E846A9EFAB7Q34563350-C2295943-8AAB-446E-A72D-66461136019BQ34589542-A91FE347-A3A0-4BAB-B9D0-630708FF4BC9Q34617414-0879CA8E-C366-4FE9-A196-D2C2B5972BDCQ34625671-DABB7D48-93E8-45BD-91D3-4F7B52DAA945Q34786090-D311FB3B-CB90-4C9B-AC41-485B77405DFAQ35064862-C608C6E7-7B31-46EB-820A-A25173AB61DCQ35108328-772FA3E8-7A33-4D5E-AFD6-779263B88DA5Q35177884-4689BFC3-81B5-4B0C-9512-537E9A21D8CEQ35541482-B559A92E-E85C-48C3-85BE-5E92A3E3765DQ35790424-985E3931-D8B4-477D-8526-0D39F8BEB0E1Q35870767-1F219540-0282-4266-9EA0-E5402387E5DAQ36052307-3D2E04B6-DA42-434E-B5E7-D0EEC40D4845Q36067465-9F06ABF7-1311-4B18-8496-1CD0D13408CFQ36092123-91F35E84-00F4-4B1A-92CD-BAE67F2FCA5A
P2860
International trends and patterns of primary liver cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
International trends and patterns of primary liver cancer.
@en
International trends and patterns of primary liver cancer.
@nl
type
label
International trends and patterns of primary liver cancer.
@en
International trends and patterns of primary liver cancer.
@nl
prefLabel
International trends and patterns of primary liver cancer.
@en
International trends and patterns of primary liver cancer.
@nl
P2093
P356
P1476
International trends and patterns of primary liver cancer.
@en
P2093
P304
P356
10.1002/IJC.1456
P577
2001-10-01T00:00:00Z